Nearly five years after the Philips Respironics recall reshaped the CPAP market, respondents to a recent HME Newspoll say ...
DONGGUAN, GUANGDONG, CHINA, January 15, 2026 /EINPresswire.com/ -- As sleep disorders such as obstructive sleep apnea ...
Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.
SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has ...
KPAP™ sleep therapy platform is designed to enable a more comfortable, adaptive, and patient-centered alternative to traditional continuous positive airway pressure (CPAP) therapy SleepRes, Inc., a ...
Put an end to sleep disruptions, from air leaks to pressure points and general discomfort. We rounded up the best CPAP ...
DONGGUAN, GUANGDONG, CHINA, January 15, 2026 /EINPresswire.com/ — As global healthcare regulations tighten and patient safety becomes the cornerstone of medical ...
The sleep apnea devices market is primarily driven by the rising prevalence of obstructive sleep apnea (OSA) and related risk factors, as well as by growing public health initiatives, awareness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results